These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31599420)

  • 1. LncRNA NBR2 inhibits EMT progression by regulating Notch1 pathway in NSCLC.
    Gao YP; Li Y; Li HJ; Zhao B
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7950-7958. PubMed ID: 31599420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
    Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer.
    Cheng D; Bao C; Zhang X; Lin X; Huang H; Zhao L
    Biomed Pharmacother; 2018 Nov; 107():1540-1547. PubMed ID: 30257372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer.
    Wu J; Weng Y; He F; Liang D; Cai L
    Anticancer Drugs; 2018 Aug; 29(7):628-636. PubMed ID: 29782349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NBR2 Regulates Cancer Cell Stemness and Predicts Survival in Non-small Cell Cancer Patients by Downregulating TGF-β1.
    Huang J; Yu Q; Zhang J; Lu W; Liu Q; Chu Y; Zhou Y; Tu R; Zhou H; Wang Q
    Curr Pharm Biotechnol; 2023; 24(8):1059-1069. PubMed ID: 35909269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
    Yu DJ; Li YH; Zhong M
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
    Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo(a)pyrene regulated A549 cell migration, invasion and epithelial-mesenchymal transition by up-regulating long non-coding RNA linc00673.
    Wu Y; Niu Y; Leng J; Xu J; Chen H; Li H; Wang L; Hu J; Xia D; Wu Y
    Toxicol Lett; 2020 Mar; 320():37-45. PubMed ID: 31778776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
    Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
    Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
    Zhu X; Guo X; Wu S; Wei L
    Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Yang J; Du YM; Li B
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA WTAPP1 promotes cancer cell invasion and migration in NSCLC by downregulating lncRNA HAND2-AS1.
    Zhang L; Jin C; Yang G; Wang B; Hua P; Zhang Y
    BMC Pulm Med; 2020 May; 20(1):153. PubMed ID: 32473628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
    Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
    J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.